Agilent Technologies 将来の成長

Future 基準チェック /26

Agilent Technologies利益と収益がそれぞれ年間9.2%と5.5%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に23.3% 10.7%なると予測されています。

主要情報

9.2%

収益成長率

10.7%

EPS成長率

Life Sciences 収益成長	15.9%
収益成長率	5.5%
将来の株主資本利益率	23.3%
アナリストカバレッジ	Good
最終更新日	21 Apr 2025

今後の成長に関する最新情報

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Nov 28

Recent updates

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

Apr 24

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Nov 28

Agilent Q4: Expecting Market Recovery In 2025

Nov 26

Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 26

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Oct 21

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Sep 23

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Sep 09

Strategic Expansion And Digital Innovation Poised To Catapult Growth In Life Sciences

Aug 29 Strategic acquisitions and innovation in biopharma and environmental testing highlight a focus on high-demand areas and regulatory changes, suggesting potential revenue growth.

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Aug 23

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Aug 14

Agilent: Making A Move To Ignite Some Growth

Jul 25

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Jul 15

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

May 23

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

May 22

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

May 07

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Mar 12

Agilent Technologies Hit A Homerun

Dec 24

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Dec 08

Agilent Technologies: Looking Undervalued Heading Into Earnings

Nov 17

業績と収益の成長予測

NYSE:A - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
10/31/2027	7,572	1,697	1,769	2,114	11
10/31/2026	7,138	1,499	1,488	1,908	18
10/31/2025	6,729	1,400	1,207	1,729	17
1/31/2025	6,533	1,259	1,312	1,697	N/A
10/31/2024	6,510	1,289	1,373	1,751	N/A
7/31/2024	6,497	1,413	1,417	1,786	N/A
4/30/2024	6,591	1,242	1,538	1,896	N/A
1/31/2024	6,735	1,236	1,649	1,961	N/A
10/31/2023	6,833	1,240	1,474	1,772	N/A
7/31/2023	6,994	1,133	1,420	1,704	N/A
4/30/2023	7,040	1,351	1,183	1,468	N/A
1/31/2023	6,930	1,323	1,061	1,353	N/A
10/31/2022	6,848	1,254	1,021	1,312	N/A
7/31/2022	6,659	1,328	1,022	1,305	N/A
4/30/2022	6,527	1,263	1,058	1,313	N/A
1/31/2022	6,445	1,205	1,280	1,502	N/A
10/31/2021	6,319	1,210	1,297	1,485	N/A
7/31/2021	6,142	990	1,268	1,421	N/A
4/30/2021	5,817	925	1,253	1,377	N/A
1/31/2021	5,530	810	1,092	1,218	N/A
10/31/2020	5,339	719	802	921	N/A
7/31/2020	5,223	691	736	858	N/A
4/30/2020	5,236	683	665	810	N/A
1/31/2020	5,236	764	598	749	N/A
10/31/2019	5,163	1,071	865	1,021	N/A
7/31/2019	5,090	1,072	917	1,079	N/A
4/30/2019	5,019	1,117	887	1,034	N/A
1/31/2019	4,987	1,140	929	1,085	N/A
10/31/2018	4,914	316	N/A	1,087	N/A
7/31/2018	4,809	298	N/A	1,003	N/A
4/30/2018	4,720	237	N/A	1,034	N/A
1/31/2018	4,616	196	N/A	988	N/A
10/31/2017	4,472	684	N/A	889	N/A
7/31/2017	4,394	633	N/A	835	N/A
4/30/2017	4,324	582	N/A	801	N/A
1/31/2017	4,241	509	N/A	798	N/A
10/31/2016	4,202	462	N/A	793	N/A
7/31/2016	4,126	476	N/A	800	N/A
4/30/2016	4,096	465	N/A	714	N/A
1/31/2016	4,040	466	N/A	643	N/A
10/31/2015	4,038	438	N/A	1,322	N/A
7/31/2015	4,046	306	N/A	1,245	N/A
4/30/2015	4,041	256	N/A	1,165	N/A
1/31/2015	4,066	204	N/A	1,307	N/A
10/31/2014	4,048	232	N/A	731	N/A
7/31/2014	4,723	435	N/A	924	N/A
4/30/2014	5,366	540	N/A	1,111	N/A

アナリストによる今後の成長予測

収入対貯蓄率: Aの予測収益成長率 (年間9.2% ) は貯蓄率 ( 2.8% ) を上回っています。

収益対市場: Aの収益 ( 9.2% ) US市場 ( 14.1% ) よりも低い成長が予測されています。

高成長収益: Aの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: Aの収益 ( 5.5% ) US市場 ( 8.1% ) よりも低い成長が予測されています。

高い収益成長: Aの収益 ( 5.5% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: Aの自己資本利益率は、3年後には高くなると予測されています ( 23.3 %)

成長企業の発掘

企業分析と財務データの現状

データ	最終更新日（UTC時間）
企業分析	2025/04/23 15:01
終値	2025/04/23 00:00
収益	2025/01/31
年間収益	2024/10/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージ	データ	タイムフレーム	米国ソース例
会社財務	10年	損益計算書キャッシュ・フロー計算書貸借対照表	SECフォーム10-K SECフォーム10-Q
アナリストのコンセンサス予想	+プラス3年	予想財務アナリストの目標株価	アナリストリサーチレポート Blue Matrix
市場価格	30年	株価配当、分割、措置	ICEマーケットデータ SECフォームS-1
所有権	10年	トップ株主インサイダー取引	SECフォーム4 SECフォーム13D
マネジメント	10年	リーダーシップ・チーム取締役会	SECフォーム10-K SECフォームDEF 14A
主な進展	10年	会社からのお知らせ	SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用^。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Agilent Technologies, Inc. 18 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、。アナリストの投稿は一日中更新されます。43

アナリスト	機関
James Francis Mainwaring	Atlantic Equities LLP
Catherine Ramsey Schulte	Baird
Ishan Majumdar	Baptista Research

Agilent Technologies 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Agilent Technologies, Inc. Provides Earnings Guidance for the Fiscal Second Quarter and Full Year of 2025

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025

Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024

Price target decreased by 7.2% to US$140

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

Recent updates

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Tariffs And Tactics: Agilent's Path Through Trade Disruption

Agilent Technologies, Inc. Announces Resignation of Heidi Kunz as Member of the Board of Directors, Member of the Compensation Committee, and A Member of the Nominating/Corporate Governance Committee, Effective May 21, 2025

Upcoming dividend of US$0.25 per share

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Now 20% undervalued after recent price drop

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Now 20% undervalued after recent price drop

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy

First quarter 2025 earnings: EPS misses analyst expectations

Agilent Technologies, Inc. Provides Earnings Guidance for the Fiscal Second Quarter and Full Year of 2025

Getting In Cheap On Agilent Technologies, Inc. (NYSE:A) Is Unlikely

Fourth quarter dividend of US$0.25 announced

Agilent Announces Quarterly Cash Dividend, Payable on April 23, 2025

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. to Report Q1, 2025 Results on Feb 26, 2025

Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?

Agilent Technologies, Inc., Annual General Meeting, Mar 13, 2025

Upcoming dividend of US$0.25 per share

Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?

Insufficient new directors

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Agilent Q4: Expecting Market Recovery In 2025

Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025

Third quarter dividend increased to US$0.25

Agilent Technologies, Inc. Increases Quarterly Cash Dividend, Payable on January 22, 2025

Agilent Technologies, Inc. Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Agilent Technologies, Inc. to Report Q4, 2024 Results on Nov 25, 2024

Insider notifies of intention to sell stock

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Third quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 23, 2024

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Strategic Expansion And Digital Innovation Poised To Catapult Growth In Life Sciences

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024

Agilent Technologies, Inc. Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. Receives FDA Approval for Mage-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent Technologies, Inc. (NYSE:A) acquired Sigsense Technologies, Inc.

Agilent: Making A Move To Ignite Some Growth

Agilent Technologies, Inc. Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit

Agilent Technologies, Inc. to Report Q3, 2024 Results on Aug 21, 2024

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index

Now 20% undervalued after recent price drop

Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary

Insider recently sold US$2.0m worth of stock

Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics

Price target decreased by 7.2% to US$140

Second quarter 2024 earnings: EPS misses analyst expectations

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

First quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency